Bio-Rad reported $598.2 million in revenues for the quarter, down from $602.6 million a year ago but surpassing the average analysts' estimate of $593.4 million.

The firm has also created a qPCR-based Staphylococcus aureus resistance gene assay with a run time of three minutes.

Available in March, the PCR-based FilmArray 2.0 platform has higher throughput and takes up a smaller footprint.

The company is offering about 2.7 million units consisting of preferred stock and warrants at $8.80 per unit. 

Meridian received the CE mark for two new Illumigene molecular diagnostic tests for Chlamydia trachomatis and Neisseria gonorrhoeae.

Multiple fluorophore detector system
Self-contained biological analysis
Oligonucleotides and methods for detecting KRAS and PIK3CA mutations
Methods of isothermal amplification using blocked primers
Primers for detecting Plasmodium
Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGE-A3-marker